Block & Leviton is investigating Alignment Healthcare following a whistleblower lawsuit accusing the company of manipulating financial results to inflate its stock price and executive pay. The allegations came after Alignment Healthcare reported strong Q1 2026 results and raised its full-year guidance, causing its stock to drop about 16.72% after the lawsuit news. Investors who suffered losses from buying Alignment Healthcare shares may be eligible for compensation. Block & Leviton may file legal action to recover losses and encourages affected investors and whistleblowers to contact them for assistance.
BASF has agreed to sell its global mining solutions business to SNF, a specialty chemical company based in France, following a strategic review of BASF's Performance Chemicals division. The deal includes BASF's mining chemicals portfolio, production ...
TDG Gold Corp. has agreed to sell a 51% interest in its Aurora West property to Freeport-McMoRan for C$110 million in cash. Freeport also has an option to increase its ownership to 75% or 100% by funding an additional C$80 million in exploration and ...
Union Station Homeless Services is requesting community help to donate 627 frozen turkeys for its annual Dinner in the Park event, aiming to serve 6,000 Thanksgiving meals. The turkey drive will be held on November 16-17 in Pasadena, California. Dona...
Timeplast, a materials company with over 9,000 customers, has launched a Regulation A+ offering open to the public to license its patented water-soluble plastic technology. This plastic dissolves in water after a programmed period, reducing plastic w...
DelveInsight's 2026 report highlights more than 100 BCMA-targeted therapies in various clinical stages, focusing on multiple myeloma and other diseases. Leading pharma companies like Pfizer, Regeneron, and AstraZeneca are advancing treatments includi...
